Bicycle Therapeutics Plc (BCYC)
4.95
+0.15
(+3.12%)
USD |
NASDAQ |
May 04, 16:00
4.95
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly) : -0.8714 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0461 |
| NuCana Plc | -0.7979 |
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.72M |
| Revenue (Quarterly) | 0.8855M |
| Total Expenses (Quarterly) | 61.61M |
| Enterprise Value | -208.99M |
| Gross Profit Margin (Quarterly) | -27.28% |
| Profit Margin (Quarterly) | -6.86K% |
| Earnings Yield | -63.90% |
| Normalized Earnings Yield | -63.90 |